X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Pharma Industry News - 09/Jan 17:01

PSMA-PET Provides Additional Risk Stratification in High-Risk Prostate Cancer

THURSDAY, Jan. 9, 2025 -- Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate-specific membrane antigen-positron emission tomography (PSMA-PET) results were positive in 84 percent of...

Articles similaires

St. Jude researchers improve brain disease diagnosis with PET imaging and ALS drug

news.medical.net - 06/Mar 06:08

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative advance from scientists at...

New research highlights wide variation in prostate cancer testing between GP practices

oncologynews.com.au - 05/Mar 19:26

A large-scale study has found huge variation between GP practices on whether they are likely to pick up prostate cancer using a blood test. The...

Lighting Up the Brain: Using PET Imaging to Detect Neurodegenerative Diseases

medindia.net - 07/Mar 18:23

bmedlinkPositron emission tomography/medlink/b (PET), a nuclear imaging technique commonly used to diagnose conditions like medlinkcancer/medlink,...

Sorry! Image not available at this time

Does Lifestyle Affect Prostate Cancer Outcomes?

factpatrol.com - 28/Feb 09:14

TOPLINE: Healthier lifestyles were associated with improved overall survival but not prostate cancer–specific survival in a multiethnic cohort of...

Sorry! Image not available at this time

Enhertu demonstrated statistically significant and clinically meaningful improvement in OS in patients with HER2 positive metastatic gastric cancer at interim analysis of DESTINYGastric04 phase 3 trial

pharmabiz.com - 05/Mar 10:17

Positive topline results from the DESTINY─Gastric04 phase 3 trial showed Enhertu (trastuzumab deruxtecan) demonstrated a statistically significant...

New technique to measure circulating tumour DNA in metastatic cancer may improve disease progression surveillance and patient outcomes

oncologynews.com.au - 05/Mar 19:30

In metastatic cancer surveillance, monitoring the actual concentrations of circulating tumour DNA (ctDNA) may be critical. Researchers showed that...

ASCO GU 2025: Talazoparib and enzalutamide combination improves survival in some patients with prostate cancer

oncologynews.com.au - 03/Mar 14:50

Patients with castration-resistant metastatic prostate cancer with or without HRR gene alterations treated with a combination of talazoparib and...

Corticosteroid use linked to higher risk of lupus pericarditis recurrence

news.medical.net - 27/Feb 03:06

A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating...

Sorry! Image not available at this time

Sotagliflozin Cuts MACE Rate in Patients With T2DM, CKD, CVD Risk Factors

drugs.com - 03/Mar 16:03

MONDAY, March 3, 2025 -- For patients with type 2 diabetes, chronic kidney disease, and additional cardiovascular risk factors, the dual...

ASCO GU 2025: Mobile prostate cancer screening clinic can help address barriers to serving high-risk communities

oncologynews.com.au - 03/Mar 14:57

A new study from the UK found that a mobile prostate cancer screening clinic called the “Man Van” helped address some barriers to screening by...